AS
Andrew Sauter
Chief Financial Officer
AmMax BioAmMax Bio Pipeline
| Drug | Indication | Phase |
|---|
| AMB-066 | Colorectal cancer with Minimal residual disease (CRC MRD) | Phase 2 |
| AMB-104 | AML and solid tumors | Discovery |
| AMB-051 | Tenosynovial giant cell tumor (TGCT) | Discovery |